Atlas Trials

Prognostic and Predictive Value of HE4 Biomarker in Metastatic Ovarian Cancer

Clinical trial NCT01768156 · COMPLETED

Trial details

NCT number
NCT01768156
Sponsor
Institut du Cancer de Montpellier - Val d'Aurelle
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Metastatic Ovarian Cancer
Start date
2010-09-24
Primary completion
2015-09-22
Enrollment
101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.